Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SAMSARA BIOCAPITAL, LLC | 10.37M | $7.0M | 5.54% | +1.87M | 2026-06-30 |
| RA CAPITAL MANAGEMENT, L.P. | 8.50M | $6.0M | 4.54% | -- | 2026-06-30 |
| AWM Investment Company, Inc. | 7.50M | $5.0M | 4.01% | +1.00M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.56M | $3.0M | 2.44% | -59.6K | 2026-06-30 |
| Longaeva Partners L.P. | 2.33M | $1.0M | 1.24% | -- | 2026-06-30 |
| Polar Asset Management Partners Inc. | 2.32M | $1.0M | 1.24% | -- | 2026-06-30 |
| Siren, L.L.C. | 2.00M | $1.0M | 1.07% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 890.6K | -- | 0.48% | -12.7K | 2026-06-30 |
| CITADEL ADVISORS LLC | 657.8K | -- | 0.35% | +381.2K | 2026-06-30 |
| MARSHALL WACE, LLP | 586.3K | -- | 0.31% | -- | 2026-06-30 |
